✦ LIBER ✦

P-500 Weekly docetaxel and vinorelbine as second-line therapy in advanced non-small cell lung cancer

✍ Scribed by Huber, R.; Schmidt, M.; Borgmeier, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second line weekly docetaxel in advanced

✍ Serke, M; Rücker, M; Schönfeld, N; Loddenkemper, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Clinical study of docetaxel-vinorelbine

✍ Jun Guo; Weiping Li; Degang Song; Zhehai Wang; Jie Liu; Changzheng Li; Zhen Chen 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 77 KB

Weekly docetaxel vs. docetaxel-based com

✍ Gebbia, Vittorio; Gridelli, Cesare; Verusio, Claudio; Frontini, Luciano; Aitini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB

P-20 Docetaxel and gemcitabine as second

✍ Bernardo, Maria Manuela; Sousa, Manuel; Nunes, Orlando; Gonçalves, Antonio; Mato 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Docetaxel and mitomycin as second-line t

✍ J. Feliu; G. Martín; J. Castro; A. Sundlov; A. Rodriguez-Jaráiz; E. Casado; M. L 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 209 KB

Weekly docetaxel as first-line therapy f

✍ Hainsworth, J.D; Burris, H.A; Morrissey, L.H; Litchy, S; Greco, F.A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB